Compare CRL & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRL | GMED |
|---|---|---|
| Founded | 1947 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1B | 11.0B |
| IPO Year | 1999 | 2012 |
| Metric | CRL | GMED |
|---|---|---|
| Price | $293.36 | $74.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 14 |
| Target Price | ★ $198.27 | $100.42 |
| AVG Volume (30 Days) | 827.6K | ★ 1.3M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 422.67 |
| EPS | N/A | ★ 2.00 |
| Revenue | $1,857,601,000.00 | ★ $2,938,931,000.00 |
| Revenue This Year | N/A | $11.13 |
| Revenue Next Year | $3.04 | $6.28 |
| P/E Ratio | ★ N/A | $37.14 |
| Revenue Growth | 10.48 | ★ 16.65 |
| 52 Week Low | $145.47 | $55.33 |
| 52 Week High | $303.31 | $101.40 |
| Indicator | CRL | GMED |
|---|---|---|
| Relative Strength Index (RSI) | 61.22 | 39.84 |
| Support Level | $267.27 | $74.10 |
| Resistance Level | $303.31 | $82.23 |
| Average True Range (ATR) | 9.37 | 1.67 |
| MACD | 0.17 | 0.02 |
| Stochastic Oscillator | 86.35 | 34.31 |
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.